Designed for process development leaders, MSAT teams, QA and manufacturing decision-makers, this webinar provides both strategic and technical perspectives on implementing scalable, in-line metabolic monitoring. Participants will gain a clear understanding of how advanced electrochemical sensing can support Quality by Design (QbD) principles, enhance process robustness, and drive more predictive, efficient batch operations.
- Understand how in-line PAT enables real-time batch control
- Evaluate continuous glucose and lactate monitoring strategies
- Translate real-time metabolic data into operational impact
Join us for a webinar discussing how continuous metabolic insight improves feeding strategies, strengthens process understanding, and supports early detection of culture stress — ultimately reducing batch risk and improving yield. As bioprocessing environments demand tighter control, faster decisions, and deeper process insight, in-line Process Analytical Technology (PAT) is redefining how batch performance is monitored and optimized. Learn how next-generation in-line PAT solutions are enabling real-time batch analysis, shifting operations from reactive, offline sample testing to continuous, data-driven process control. By embedding advanced sensor technologies directly into the manufacturing workflow, teams can reduce variability and media consumption, enhance reproducibility, and accelerate development timelines.
A key focus of the session will be continuous glucose and lactate monitoring using electrochemical sensor technology that is media-agnostic and non-invasive to cell culture systems. Attendees will learn how this approach delivers accurate, real-time metabolic data without altering media composition, disrupting sterility, or requiring complex recalibration across different formulations. We will also explore how clinical settings are using proprietary sensor technology for non-destructive batch release testing on their tissue grafts.